Most importantly, positive expression of p-Akt, p-mTOR and p-eIF4E in NSCLC patients with lymph node metastasis (LNM) was significantly higher than those without LNM (P = 0.033, P = 0.025 and P = 0.036, respectively). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.